Reply To: Bortezomib During DI for T Cell Lymphoma

  • Breanne Roche

    Member
    May 5, 2022 at 8:31 pm

    Hi Kathy,

    We have not been using it routinely for newly diagnosed patients, it is not our standard of care, so I cannot help you! Do you plan on using it during Induction and DI for your patient? 

    I am curious to see what institutions have transitioned it as their standard of care!

    Breanne 

    ——————————
    Breanne Roche, DNP, RN, CPNP
    Pediatric Nurse Practitioner
    Rainbow Babies & Children’s Hospital
    Cleveland, Ohio
    ——————————
    ——————————————-
    Original Message:
    Sent: 05-05-2022 02:13 PM
    From: Katherine Trimble
    Subject: Bortezomib During DI for T Cell Lymphoma

    HI Breanne,
    We have a newly diagnosed patient with T-cell lymphoma. WE are planning to give the bortezomib 1.4.8 and 11.
    We are having difficulty getting insurance approval. BCBS. We did a peer to peer.  Send references.
    Did you have difficulty? Do you have any suggestions?
    Thank you,
    Kathy Trimble MSN, RN, CPNP
    Pediatric Hematology/Oncology Nurse Practitioner
    Northwestern Medicine Central DuPage Hospital
    Winfield, IL

    ——————————
    Katherine Trimble, CPHON,CPNP,MSN,RN
    Pediatric Oncology Nurse Educator
    Winfield, IL
    United States
    ——————————

    Original Message:
    Sent: 05-05-2022 12:48 PM
    From: Breanne Roche
    Subject: Bortezomib During DI for T Cell Lymphoma

    Hi,

    I was wondering what institutions are using bortezomib during DI for T Cell lymphoma patients. If you are using it, are you giving it on Days 1, 4, 8, & 11?

    Thanks, 

    Bre

    ——————————
    Breanne Roche, DNP, RN, CPNP
    Pediatric Nurse Practitioner
    Rainbow Babies & Children’s Hospital
    Cleveland, Ohio
    ——————————